Benevolent AI (Benevolent AI) Receivables Turnover : 0.26 (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Benevolent AI Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Benevolent AI's Revenue for the three months ended in Dec. 2023 was $2.58 Mil. Benevolent AI's average Accounts Receivable for the three months ended in Dec. 2023 was $9.99 Mil. Hence, Benevolent AI's Receivables Turnover for the three months ended in Dec. 2023 was 0.26.

Benevolent AI Receivables Turnover Historical Data

The historical data trend for Benevolent AI's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Benevolent AI Receivables Turnover Chart

Benevolent AI Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Receivables Turnover

Get a 7-Day Free Trial

Benevolent AI Quarterly Data
	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Receivables Turnover	Get a 7-Day Free Trial				-	0.73	0.85	0.67	0.26

Competitive Comparison of Benevolent AI's Receivables Turnover

For the Biotechnology subindustry, Benevolent AI's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Benevolent AI's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Benevolent AI's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Benevolent AI's Receivables Turnover falls into.

Benevolent AI Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Benevolent AI's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

	Receivables Turnover (A: Dec. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2023 )	/ (	(Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )
=	9.28	/ (	(0	+	0)	/	1 )
=	9.28	/	0
=	N/A

Benevolent AI's Receivables Turnover for the quarter that ended in Dec. 2023 is calculated as

	Receivables Turnover (Q: Dec. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Dec. 2023 )	/ (	(Accounts Receivable (Q: Jun. 2023 )	+	Accounts Receivable (Q: Dec. 2023 ))	/	count )
=	2.575	/ (	(9.985	+	0)	/	1 )
=	2.575	/	9.985
=	0.26

Benevolent AI (GREY:BAIVF) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Benevolent AI Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Benevolent AI's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Benevolent AI (Benevolent AI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Benevolent AI (GREY:BAIVF) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

BAI:Netherlands 2XA:Germany

Address

4-8 Maple Street, London, GBR, W1T 5HD

Website

https://www.benevolent.com

Benevolent AI is a clinical-stage AI-enabled drug discovery company. It delivers novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform powers a growing in-house pipeline of over 20 drug programmes, spanning from target discovery to clinical studies, and it maintains commercial collaborations with pharmaceutical companies.